| NCT ID | NCT07478185 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Massachusetts, Worcester |
| Condition | Pancreatic Cancer, Adult |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-03-31 |
| Primary Completion | 2028-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-03-31 with a primary completion date of 2028-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical study is to test whether a structured prehabilitation program can be successfully used by adults with pancreatic cancer who are receiving chemotherapy before planned surgery. Prehabilitation is a program designed to improve a person's physical fitness, nutrition, and symptom control before surgery. The study's main hypothesis is that patients with pancreatic cancer can take part in and adhere to a multimodal prehabilitation program during chemotherapy, and that doing so may improve physical function, patient experience, and early recovery after surgery.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Diagnosis of pancreatic ductal adenocarcinoma (PDAC) * Planned neoadjuvant chemotherapy prior to planned surgical resection * Medically stable and cleared to participate in physical activity/exercise programming * Able to provide informed consent * Ability to read, write and understand English Exclusion Criteria: * Age \<18 years * Pregnant * Prisoner * Severe cognitive impairment that precludes informed consent or participation * Contraindications to physical activity, including unstable cardiac disease, severe pulmonary disease, or recent myocardial infarction
Contact & Investigator
James M Lindberg, MD
PRINCIPAL INVESTIGATOR
UMass Memorial Health
Frequently Asked Questions
Who can join the NCT07478185 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Cancer, Adult. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07478185 currently recruiting?
Yes, NCT07478185 is actively recruiting participants. Contact the research team at kayla.widdowson@umassmed.edu for enrollment information.
Where is the NCT07478185 trial being conducted?
This trial is being conducted at Worester, United States.
Who is sponsoring the NCT07478185 clinical trial?
NCT07478185 is sponsored by University of Massachusetts, Worcester. The principal investigator is James M Lindberg, MD at UMass Memorial Health. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.